EndocrineICD-10: E16.2Affects the majority of people with type 1 diabetes and many with insulin-treated type 2 diabetes

Hypoglycemia (Low Blood Sugar)

Also known as: Low Blood Sugar, Insulin Reaction, Low Blood Glucose, Sugar Crash

Hypoglycemia occurs when blood glucose levels drop below 70 mg/dL, causing a range of symptoms from mild shakiness and sweating to severe confusion, seizures, and loss of consciousness. It is most commonly associated with diabetes treatment, particularly insulin and certain oral medications, but can also occur in people without diabetes due to other medical conditions. Prompt recognition and treatment of hypoglycemia is critical, as prolonged severely low blood sugar can cause brain damage and can be life-threatening.

Last updated November 10, 2026

Understanding Hypoglycemia (Low Blood Sugar)

Hypoglycemia is a blood glucose low enough to cause harm, and the American Diabetes Association defines it in three levels. Level 1 is a glucose below 70 mg/dL (3.9 mmol/L), the point at which treatment is needed. Level 2 is below 54 mg/dL (3.0 mmol/L), the threshold at which the brain starts to run short of fuel and confusion, slurred speech and behavioral change appear. Level 3, severe hypoglycemia, is any episode in which the person is too impaired to treat themselves, regardless of the number. In people without diabetes, a glucose below 55 mg/dL with symptoms that resolve on correction (Whipple's triad) is the working definition. Nearly everyone with type 1 diabetes has symptomatic lows, averaging one or two a week, and severe episodes occur in roughly a third of people with type 1 each year and in about 10 percent of those with insulin-treated type 2. Insulin-related hypoglycemia causes about 100,000 US emergency department visits annually, a third of them ending in admission, with people over 80 five times more likely to be hospitalized than middle-aged adults.

A healthy body defends its glucose in layers. As glucose falls to about 80 mg/dL, insulin secretion shuts off; at 65 to 70, glucagon and adrenaline are released to push the liver to make and release glucose and produce the warning symptoms: shakiness, sweating, hunger, pounding heart; by about 55, thinking slows; below 50 the brain's own symptoms of confusion, blurred vision and drowsiness take over, and seizures or coma follow if the fall continues. Injected insulin and sulfonylureas cannot be switched off, which removes the first defense. In type 1 diabetes the glucagon response is lost within a few years, and each episode of hypoglycemia blunts the adrenaline response to the next, a cycle called hypoglycemia-associated autonomic failure that produces hypoglycemia unawareness. Alcohol blocks the liver's glucose production for many hours, exercise raises insulin sensitivity for up to 24 to 48 hours, and kidney disease prolongs the action of insulin and sulfonylureas. In people without diabetes, lows after meals (reactive or, increasingly, post-bariatric-surgery hypoglycemia) come from an exaggerated insulin surge one to three hours after rapidly absorbed carbohydrate.

Treatment of a conscious person follows the 15-15 rule in the ADA Standards of Care: take 15 grams of fast-acting carbohydrate, recheck after 15 minutes, repeat if still below 70, and once recovered eat a snack or meal if the next one is more than an hour away. Severe hypoglycemia is an emergency: anyone who is confused, unable to swallow safely, seizing or unconscious needs glucagon (nasal spray or auto-injector) and a call to 911, and nothing should be put in the mouth. Continuous glucose monitors with low alerts cut hypoglycemic events by 72 percent in a 149-person trial of people with impaired awareness, and automated insulin delivery systems reduce time below 70 to under the 4 percent target. Guidelines now set a target of less than 1 percent of time below 54 mg/dL, recommend relaxed glucose goals for older or frail adults, favor replacing sulfonylureas with drugs that do not cause lows, and prescribe glucagon to everyone on insulin. In people without diabetes, a supervised fast with insulin, C-peptide, proinsulin and sulfonylurea screening identifies the cause.

Natural approaches matter in hypoglycemia mostly as things to avoid. Supplements marketed for 'blood sugar support' lower glucose by design: berberine, cinnamon, bitter melon, gymnema, fenugreek, alpha-lipoic acid, banaba and chromium have each been shown to reduce glucose in trials, which means that stacked on insulin or a sulfonylurea they can trigger a low without warning, and none has been shown to prevent one. If you take them, tell your prescriber and watch your readings. The exception is post-meal (reactive) hypoglycemia in people not on glucose-lowering drugs, where diet is the mainstay and a few supplements have small supporting studies. Soluble fiber such as psyllium or glucomannan taken with meals slows carbohydrate absorption and flattens the glucose peak that provokes the insulin overshoot, and glucomannan prevented late post-meal lows in children with dumping syndrome. Chromium picolinate raised the glucose trough and improved symptoms in an eight-person study of reactive hypoglycemia. Protein and fat with every carbohydrate serving, avoiding liquid sugar and alcohol on an empty stomach, and eating smaller, more frequent meals have better support than any capsule.

The most common mistake is over-treating. Panic and hunger during a low lead people to eat a sandwich, a bowl of cereal or a bag of candy, which sends glucose to 250 an hour later, prompts a correction dose of insulin, and sets up the next low: the familiar rollercoaster. Fifteen grams, wait fifteen minutes, repeat if needed, then stop. Chocolate, cookies and milk are poor choices because their fat and protein slow the sugar down. The second mistake is treating an unconscious or confused person with juice or honey in the mouth; they can inhale it. Use glucagon, turn them on their side and call 911. The third is ignoring night-time lows, which announce themselves as night sweats, nightmares, a damp pillow, a morning headache or an unexplained high fasting reading; a bedtime check, a CGM with alerts or an occasional 3 a.m. reading finds them.

At a Glance

Common symptoms
Shakiness and trembling, Sweating, chills, and clamminess, Rapid heartbeat (tachycardia)
Main treatments
Rule of 15: consume 15 grams of fast-acting carbohydrates and recheck blood sugar after 15 minutes, Glucose tablets or gel for rapid blood sugar elevation, Glucagon injection or nasal spray for severe hypoglycemia when the person cannot eat
Category
Endocrine · Affects the majority of people with type 1 diabetes and many with insulin-treated type 2 diabetes
See a doctor if
You experience recurrent episodes of hypoglycemia despite medication adjustments

Symptoms

Shakiness and trembling
Sweating, chills, and clamminess
Rapid heartbeat (tachycardia)
Anxiety, irritability, and confusion
Dizziness or lightheadedness
Hunger and nausea
Blurred vision
Seizures and loss of consciousness in severe cases

Causes

  • Excessive insulin or diabetes medication dosing
  • Skipping meals or not eating enough carbohydrates
  • Increased physical activity without adjusting food or medication
  • Alcohol consumption, which impairs the liver's ability to release glucose
  • Insulinoma (insulin-producing pancreatic tumor) in non-diabetic hypoglycemia
  • Adrenal or pituitary gland insufficiency

Risk Factors

  • Type 1 or type 2 diabetes treated with insulin or sulfonylureas
  • Irregular meal timing or inadequate food intake
  • Heavy alcohol use
  • Kidney or liver disease affecting glucose metabolism
  • Elderly age with decreased appetite and renal function
  • Intensive blood sugar control targeting low HbA1c levels

Diagnosis

  • Blood glucose measurement showing levels below 70 mg/dL
  • Whipple's triad: low glucose, symptoms of hypoglycemia, and symptom resolution after glucose administration
  • Fasting blood tests to evaluate for non-diabetic causes
  • Insulin and C-peptide levels to distinguish between causes
  • CT or MRI of the pancreas if insulinoma is suspected

Treatment

  • Rule of 15: consume 15 grams of fast-acting carbohydrates and recheck blood sugar after 15 minutes
  • Glucose tablets or gel for rapid blood sugar elevation
  • Glucagon injection or nasal spray for severe hypoglycemia when the person cannot eat
  • Adjustment of diabetes medication dosing by the healthcare provider
  • IV dextrose in emergency settings for unconscious patients
  • Dietary counseling to prevent recurrent episodes

Natural remedies for hypoglycemia (low blood sugar): what the evidence says

Ranked by the strength of human evidence for hypoglycemia (low blood sugar) specifically. These sit alongside medical care, not in place of it.

  1. Psyllium Husk

    Preliminary evidence

    A 2015 meta-analysis of 35 randomized trials found psyllium taken before meals lowered post-meal and fasting glucose in people with type 2 diabetes (fasting glucose fell by about 37 mg/dL), by forming a gel that slows carbohydrate absorption. In reactive hypoglycemia the same slowing blunts the glucose spike that triggers the insulin overshoot, and clinical experience and small studies of soluble fiber in dumping syndrome support this, although no randomized trial has been done in reactive hypoglycemia specifically. It is for diet-managed post-meal lows, not for lows caused by insulin or sulfonylureas.

    Studied dose
    3.5 to 7 g psyllium husk in a full glass of water taken 5 to 10 minutes before the two largest meals of the day.
    Cautions
    Take with plenty of water and separate from all medications by 2 hours, since it can bind them. In people on insulin or sulfonylureas, the added slowing of absorption can itself cause lows, so doses may need adjusting with the prescriber.
  2. Glucomannan

    Preliminary evidence

    Glucomannan is one of the most viscous dietary fibers, and in a study of children with dumping syndrome after stomach surgery, 1.3 g given with a glucose load prevented the late hypoglycemia that occurred without it, flattening both the glucose peak and the trough. Trials in type 2 diabetes show lower post-meal glucose, and small studies in adults after bariatric surgery suggest fewer symptomatic lows. The evidence base is small, mostly older and unblinded.

    Studied dose
    1 to 1.3 g glucomannan powder or capsules with 8 ounces of water taken just before meals that have previously caused symptoms.
    Cautions
    Must be taken with a full glass of water; tablets have caused esophageal obstruction when taken dry. Separate from medications by at least 2 hours and avoid with swallowing difficulties or a history of bowel obstruction.
  3. Chromium

    Preliminary evidence

    In a double-blind crossover study of eight people with documented reactive hypoglycemia, 200 mcg of chromium daily for three months raised the lowest glucose reached after a glucose load, improved insulin sensitivity and reduced symptoms compared with placebo. Larger trials in type 2 diabetes show small reductions in fasting glucose and A1c in some populations and none in others. The reactive hypoglycemia evidence rests on a single tiny study and has not been replicated.

    Studied dose
    200 mcg chromium picolinate once daily with a meal, studied for 3 months.
    Cautions
    Because chromium improves insulin action, it can deepen lows in people taking insulin or sulfonylureas. Rare reports of kidney and liver injury at high doses; avoid above 1,000 mcg daily and in kidney disease.

What matters day to day

  • Check your glucose before driving and do not drive below 70 mg/dL; after treating a low, wait 30 to 45 minutes before getting behind the wheel, because judgment and reaction time recover more slowly than the number on the meter.
  • Carry two 15-gram doses of fast carbohydrate at all times (glucose tablets, gel or small juice boxes) and keep glucagon where family, coworkers or roommates can find it: most severe lows happen away from a kitchen, and a third of people with a severe episode need a second treatment.
  • If you drink alcohol, eat carbohydrate with it, check before bed and expect a delayed effect: alcohol blocks the liver's glucose output for up to 12 to 24 hours, so a low can arrive the next morning long after you feel sober.
  • Plan for exercise: check before, carry carbohydrate, and discuss reducing mealtime insulin by 25 to 75 percent for activity within 2 to 3 hours of a dose, since insulin sensitivity stays raised for up to 48 hours and night-time lows after afternoon exercise are common.
  • Use a continuous glucose monitor with low alerts if you take insulin, and share the data with someone you trust: in trials, alarms reduced hypoglycemic events by about 70 percent in people with impaired awareness, and overnight alerts catch the lows that cause the most harm.
  • Rotate injection or infusion sites and avoid lumpy, scarred areas: injecting into lipohypertrophy makes insulin absorption erratic and is a common, overlooked cause of unexplained swings between highs and lows.

Prevention

  • Monitor blood glucose regularly, especially before and after exercise
  • Eat regular meals and snacks, particularly when taking diabetes medications
  • Adjust insulin and medication doses before planned physical activity
  • Carry fast-acting glucose sources (glucose tablets, juice) at all times
  • Limit alcohol consumption and never drink on an empty stomach
  • Wear a medical alert bracelet identifying diabetes and hypoglycemia risk

When to See a Doctor

  • You experience recurrent episodes of hypoglycemia despite medication adjustments
  • Hypoglycemia causes loss of consciousness, seizure, or confusion
  • You have symptoms of low blood sugar but do not have diabetes
  • Hypoglycemia unawareness develops (loss of warning symptoms)

Frequently Asked Questions

References

  1. American Diabetes Association Professional Practice Committee. Glycemic goals and hypoglycemia: Standards of Care in Diabetes-2025. Diabetes Care (2025)
  2. International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2017)
  3. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. New England Journal of Medicine (2013)
  4. Cryer PE, Axelrod L, Grossman AB, et al.. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism (2009)
  5. Geller AI, Shehab N, Lovegrove MC, et al.. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Internal Medicine (2014)
  6. Heinemann L, Freckmann G, Ehrmann D, et al.. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet (2018)
  7. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia (2007)
  8. Anderson RA, Polansky MM, Bryden NA, et al.. Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism (1987)
  9. Gibb RD, McRorie JW, Russell DA, et al.. Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. American Journal of Clinical Nutrition (2015)
  10. National Institute of Diabetes and Digestive and Kidney Diseases. Low Blood Glucose (Hypoglycemia) (2021)View source

Related Conditions

Have questions about Hypoglycemia (Low Blood Sugar)?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.